Literature DB >> 9895354

Measurement of glial fibrillary acidic protein in human blood: analytical method and preliminary clinical results.

U Missler1, M Wiesmann, G Wittmann, O Magerkurth, H Hagenström.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9895354

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  54 in total

1.  Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention.

Authors:  Linda Papa; Lawrence M Lewis; Jay L Falk; Zhiqun Zhang; Salvatore Silvestri; Philip Giordano; Gretchen M Brophy; Jason A Demery; Neha K Dixit; Ian Ferguson; Ming Cheng Liu; Jixiang Mo; Linnet Akinyi; Kara Schmid; Stefania Mondello; Claudia S Robertson; Frank C Tortella; Ronald L Hayes; Kevin K W Wang
Journal:  Ann Emerg Med       Date:  2011-11-08       Impact factor: 5.721

Review 2.  Predictive biomarkers of recovery in traumatic brain injury.

Authors:  Sabrina Giacoppo; Placido Bramanti; Marina Barresi; Debora Celi; Valeria Foti Cuzzola; Eleonora Palella; Silvia Marino
Journal:  Neurocrit Care       Date:  2012-06       Impact factor: 3.210

Review 3.  Blood-based diagnostics of traumatic brain injuries.

Authors:  Stefania Mondello; Uwe Muller; Andreas Jeromin; Jackson Streeter; Ronald L Hayes; Kevin K W Wang
Journal:  Expert Rev Mol Diagn       Date:  2011-01       Impact factor: 5.225

4.  Decoding the iceman's death?

Authors:  Christian Foerch
Journal:  Cell Mol Life Sci       Date:  2013-12-11       Impact factor: 9.261

Review 5.  Current status of fluid biomarkers in mild traumatic brain injury.

Authors:  Jacqueline R Kulbe; James W Geddes
Journal:  Exp Neurol       Date:  2015-05-14       Impact factor: 5.330

6.  Correlation of Blood Biomarkers and Biomarker Panels with Traumatic Findings on Computed Tomography after Traumatic Brain Injury.

Authors:  Jussi P Posti; Riikka S K Takala; Linnéa Lagerstedt; Alex M Dickens; Iftakher Hossain; Mehrbod Mohammadian; Henna Ala-Seppälä; Janek Frantzén; Mark van Gils; Peter J Hutchinson; Ari J Katila; Henna-Riikka Maanpää; David K Menon; Virginia F Newcombe; Jussi Tallus; Kevin Hrusovsky; David H Wilson; Jessica Gill; Jean-Charles Sanchez; Olli Tenovuo; Henrik Zetterberg; Kaj Blennow
Journal:  J Neurotrauma       Date:  2019-04-05       Impact factor: 5.269

7.  Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones.

Authors:  J Steiner; H Bielau; H-G Bernstein; B Bogerts; M T Wunderlich
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11       Impact factor: 10.154

8.  Influence of Matrix Metallopeptidase 9 on Beta-Amyloid Elimination Across the Blood-Brain Barrier.

Authors:  Ben Shackleton; Charis Ringland; Laila Abdullah; Michael Mullan; Fiona Crawford; Corbin Bachmeier
Journal:  Mol Neurobiol       Date:  2019-06-18       Impact factor: 5.590

9.  Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke.

Authors:  C Foerch; I Curdt; B Yan; F Dvorak; M Hermans; J Berkefeld; A Raabe; T Neumann-Haefelin; H Steinmetz; M Sitzer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09-20       Impact factor: 10.154

Review 10.  Blood biomarkers for brain injury: What are we measuring?

Authors:  Keisuke Kawata; Charles Y Liu; Steven F Merkel; Servio H Ramirez; Ryan T Tierney; Dianne Langford
Journal:  Neurosci Biobehav Rev       Date:  2016-05-12       Impact factor: 8.989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.